Voluntarily exposure to a single, high dose of probiotic Escherichia coli results in prolonged colonisation

Beneficial Microbes

Volumn 5, Issue 4, 2014, Pages 367-375

  Wassenaar, T M ^a   Beimfohr, C ^b   Geske, T ^c   Zimmermann, K ^d  

^a Tannenstrasse 7   (Germany)

^b Vermicon AG   (Germany)

^c BG Bau Oberhausen   (Germany)

^d SymbioPharm GmbH   (Germany)

Author keywords

Colonisation; Colonisation fitness; Escherichia coli; Persistence; Probiotic

Indexed keywords

PROBIOTIC AGENT;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIUM DETECTION; COLONY FORMING UNIT; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; INTESTINE FLORA; MALE; ADVERSE DRUG REACTION; BACTERIAL LOAD; FECES; FOLLOW UP; GASTROINTESTINAL TRACT; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; MIDDLE AGED; NORMAL HUMAN; PATHOLOGY; TIME;

ADULT; BACTERIAL LOAD; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; ESCHERICHIA COLI; FECES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL TRACT; HEALTHY VOLUNTEERS; HUMANS; MALE; MIDDLE AGED; PROBIOTICS; TIME FACTORS;

EID: 84907024722     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2013.0087     Document Type: Article

References (15)

1. Giese, T., Zimmermann, K. and Meuer, S.C., 2003. Functional characterization of pro-biotic pharmaceuticals by quantitative analysis of gene expression. Arzneimittelforschung 53: 385-391.
2. Jansen, G.J., Wildeboer-Veloo, A.C., Van der Waaij, D. and Degener, J.E., 1998. Escherichia coli as a probiotic? Infection 26: 232-233.
3. Knothe, H., 1998. The story of live human intestinal bacteria administered orally as a remedy. Infection 23: 201-202.
4. Lukjancenko, O., Wassenaar, T.M. and Ussery, D.W., 2010. Comparison of 61 sequenced Escherichia coli genomes. Microbial Ecology 60: 708-720.
5. Lyra, A., Forssten, S., Rolny, P., Wettergren, Y., Lahtinen, S.J., Salli, K., Cedga˚rd, L., Odin, E., Gustavsson, B. and Ouwehand, A.C., 2012. Comparison of bacterial quantities in left and right colon biopsies and faeces. World Journal of Gastroenterology 18: 4404-4411.
6. Panigrahi, P., Parida, S., Pradhan, L., Mohapatra, S.S., Misra, P.R., Johnson, J.A., Chaudhry, R., Taylor, S., Hansen, N.I. and Gewolb, I.H., 2008. Long-term colonization of a Lactobacillus plantarum synbiotic preparation in the neonatal gut. Journal of Pediatric Gastroenterology and Nutrition 47: 45-53.
7. Piano, M.D., Carmagnola, S., Ballare`, M., Balzarini, M., Montino, F., Pagliarulo, M., Anderloni, A., Orsello, M., Tari, R., Sforza, F., Mogna, L. and Mogna, G., 2012. Comparison of the kinetics of intestinal colonization by associating 5 probiotic bacteria assumed either in a microencapsulated or in a traditional, uncoated form. Journal of Clinical Gastroenterology 46 Suppl.: S85-S92.
8. Prilassnig, M., Wenisch, C., Daxboeck, F. and Feierl, G., 2007. Are probiotics detectable in human feces after oral uptake by healthy volunteers? Wiener Klinische Wochenschrift 119: 456-462.
9. Sambrook, J. and Russell, D.W. (eds.), 2001. Molecular cloning: a laboratory manual. 3rd ed. Cold Spring Harbor Press, New York, NY, USA.
10. Sanz, Y., Nadal, I. and Sa´nchez, E., 2007. Probiotics as drugs against human gastrointestinal infections. Recent Patents on Anti-infective Drug Discovery 2: 148-156.
11. Smith, T.J., Anderson, D., Margolis, L.M., Sikes, A. and Young, A.J., 2011. Persistence of Lactobacillus reuteri DSM17938 in the human intestinal tract: response to consecutive and alternate-day supplementation. Journal of the American College of Nutrition 30: 259-264.
12. Stecher, B., Chaffron, S., Ka¨ppeli, R., Hapfelmeier, S., Freedrich, S., Weber, T.C., Kirundi, J., Suar, M., McCoy, K.D., Von Mering, C., Macpherson, A.J. and Hardt, W.D., 2010. Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathogens 6: e1000711.
13. Tannock, G.W., Tiong, I.S., Priest, P., Munro, K., Taylor, C., Richardson, A. and Schultz, M., 2011. Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrugresistant E. coli by elderly residents in long-term care facilities. Journal of Medical Microbiology 60: 366-370.
14. Tobin, J.M., Garland, S.M., Jacobs, S.E., Pirotta, M. and Tabrizi, S.N., 2013. Rapid assay to assess colonization patterns following in vivo probiotic ingestion. BMC Research Notes 6: 252.
15. Zschu¨ttig, A., Zimmermann, K., Blom, J., Goesmann, A., Po¨hlmann, C. and Gunzer, F., 2012. Identification and characterization of microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3/10. PLoS One 7: e33351.